MedPath

Empowered Relief for Youth

Not Applicable
Recruiting
Conditions
Fibromyalgia
Abdominal Pain
Chronic Pain
Neuropathic Pain
Musculoskeletal Pain
Complex Regional Pain Syndromes
Interventions
Behavioral: Empowered Relief for Youth
Registration Number
NCT05998369
Lead Sponsor
Stanford University
Brief Summary

The purpose of this pilot study is to examine the feasibility and preliminary efficacy of Empowered Relief for Youth with chronic pain (ER-Y). ER-Y is a single-session pain management class for youth focused on pain science education and teaching self-regulatory skills for pain management based on the evidence-based adult ER class. Feasibility and acceptability of ER-Y will be assessed post-class. Preliminary efficacy will be assessed by administering surveys at baseline, 4-weeks, 8-weeks, and 12-weeks post class.

Detailed Description

The current proposed, single-arm, uncontrolled pilot study will determine a) feasibility of ER-Y in youth with chronic pain, b) patients' perceptions and satisfaction of the ER-Y class and c) preliminary efficacy to inform the design of a subsequent randomized controlled trial.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age at least 10 years old to 18 years
  • Diagnosis of Chronic Pain
  • English speaking
Exclusion Criteria
  • Diagnosis of neurological conditions such as seizures, cerebral palsy, developmental delay
  • Severe affective disorder (e.g., severe depression/ anxiety) from medical record review.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Empowered Relief for YouthEmpowered Relief for YouthEmpowered Relief for Youth is a single-session pain management class focused on pain science education and teaching self-regulatory skills for pain management based on the evidence-based adult ER class.
Primary Outcome Measures
NameTimeMethod
Treatment Expectancy Credibility (TEC-C)Immediately post class

The TEC-C assess treatment expectations and credibility with standardized sum scores from using a numeric rating scale (score 0 = "not at all" to 10 = "very much") with a higher score indicating high expectations.

Program Feedback ScaleImmediately post class

The Program Feedback Scale assesses participants agreement to seven statements indicating their perceived acceptability and feasibility based on a scale (score 0 = "really disagree" to 4 = "really agree") with a higher score indicating positive feedback and two open ended questions.

Secondary Outcome Measures
NameTimeMethod
Pain Catastrophizing Scale (PCS)Pre class, 4 weeks, 8 weeks, and 12 weeks post class

The Pain Catastrophizing Scale -Child Version (PCS-C, Crombez et al., 2003) assesses negative cognitions associated with pain. The PCS-C is comprised of 13-items rated on a 5-point Likert scale (score 0= "not at all true" to 4 "very true"). A total score (0-52) is obtained by summing all items. Higher scores indicate higher levels of catastrophic thinking.

Patient Global Impression of Change (PGIC)4 weeks, 8 weeks, and 12 weeks post class

The Pain Global Impression of Change survey asks participants to rank how their overall pain has changed since the start of study using a ranked scale (score 0 = "very much improved" to 6 = "very much worse") with higher scores indicating greater severity to their pain.

PROMIS Pain InterferencePre class, 4 weeks, 8 weeks, and 12 weeks post class

The PROMIS Pain Interference form assesses to what level pain hinders their engagement in several activities using a ranked scale (score 0 = "never" to 4 = "almost always") with a higher score indicating great pain interference.

Trial Locations

Locations (1)

Stanford University

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath